Latest News and Press Releases

§  3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens §  Finalizing contracts with two Long COVID clinics to recruit patients §  Institutional Review Board (IRB)...

New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...

New York, NY, and Tel Aviv, ISRAEL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and...

§  Lesion swab (standard of care) and saliva-based sample collection planned §  Peer-reviewed publication demonstrating saliva testing sensitivity opens door for asymptomatic testing New York,...

New York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...

NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...

New York, NY, and Tel Aviv, ISRAEL, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...

New York, NY, and Tel Aviv, ISRAEL, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...

§  Biomarker data correlates with clinical data announced in January 2022 §  46 patient open label extension being opened to support US FDA EUA application  New York, NY, and Tel Aviv, ISRAEL,...